Aller au contenu principal

Recherche sur le site

Séminaire de Médecine Nucléaire

Outcome prediction to treatment with 177Lu-PSMA-RLT in men with metastatic castration resistant prostate cancer. Retrospective analysis from a monocentric cohort."

Séminaire de Médecine Nucléaire

Predicting overall survival using 18F-FDG PET/CT-based biomarkers for clinical decision support in metastatic colorectal cancer - Dr Jennifer Dhont

Meet the Oncology Expert

Clinical development of innovative therapeutic anti-cancer vaccines ? Olivier ADOTEVI, MD PhD ,Regional Cancer Institute of Franche-Comté

Meet the Oncology Expert

AI in pathology: from sandbox to implementation in clinical practice (Paul J. Van DIEST, MD PhD (The Netherlands)